Stereotaxis

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Stereotaxis and other ETFs, options, and stocks.

About STXS

Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. 

CEO
David Leo Fischel
CEODavid Leo Fischel
Employees
139
Employees139
Headquarters
St. Louis, Missouri
HeadquartersSt. Louis, Missouri
Founded
1990
Founded1990
Employees
139
Employees139

STXS Key Statistics

Market cap
196.45M
Market cap196.45M
Price-Earnings ratio
-7.90
Price-Earnings ratio-7.90
Dividend yield
Dividend yield
Average volume
923.18K
Average volume923.18K
High today
$2.22
High today$2.22
Low today
$2.10
Low today$2.10
Open price
$2.16
Open price$2.16
Volume
628.74K
Volume628.74K
52 Week high
$3.59
52 Week high$3.59
52 Week low
$1.54
52 Week low$1.54

Stock Snapshot

Stereotaxis(STXS) stock is priced at $2.11, giving the company a market capitalization of 196.45M. It carries a P/E multiple of -7.90.

During the trading session on 2025-11-17, Stereotaxis(STXS) shares reached a daily high of $2.22 and a low of $2.10. At a current price of $2.11, the stock is +0.2% higher than the low and still -5.2% under the high.

Trading volume for Stereotaxis(STXS) stock has reached 628.74K, versus its average volume of 923.18K.

Over the past 52 weeks, Stereotaxis(STXS) stock has traded between a high of $3.59 and a low of $1.54.

Over the past 52 weeks, Stereotaxis(STXS) stock has traded between a high of $3.59 and a low of $1.54.

STXS News

TipRanks 5d
Stereotaxis Earnings Call: Growth Amid Challenges

Stereotaxis ((STXS)) has held its Q3 earnings call. Read on for the main highlights of the call. Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst...

TipRanks 6d
Strategic Advancements and FDA Clearance Propel Stereotaxis’s Growth Potential

Stereotaxis, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Josh Jennings from TD Cowen reiterated a Buy rating on the sto...

People also own

Based on the portfolios of people who own STXS. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.